GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Additional Paid-In Capital

Optimind Pharma (XCNQ:OMND) Additional Paid-In Capital : C$0.04 Mil(As of Nov. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma Additional Paid-In Capital?


Optimind Pharma's quarterly additional paid-in capital stayed the same from May. 2023 (C$0.04 Mil) to Aug. 2023 (C$0.04 Mil) and stayed the same from Aug. 2023 (C$0.04 Mil) to Nov. 2023 (C$0.04 Mil).

Optimind Pharma's annual additional paid-in capital stayed the same from . 20 (C$0.00 Mil) to Feb. 2022 (C$0.00 Mil) but then increased from Feb. 2022 (C$0.00 Mil) to Feb. 2023 (C$0.04 Mil).

Optimind Pharma Additional Paid-In Capital Historical Data

The historical data trend for Optimind Pharma's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma Additional Paid-In Capital Chart

Optimind Pharma Annual Data
Trend Feb22 Feb23
Additional Paid-In Capital
- 0.04

Optimind Pharma Quarterly Data
Jun21 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
Additional Paid-In Capital Get a 7-Day Free Trial 0.06 0.04 0.04 0.04 0.04

Optimind Pharma Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Optimind Pharma Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimind Pharma (XCNQ:OMND) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Additional Paid-In Capital
Comparable Companies
XCNQ:NLV TSXV:GENX XCNQ:AYUR XCNQ:PHRX XCNQ:J XCNQ:CRCC XCNQ:BCBC XCNQ:CVGR XCNQ:PBF TSXV:HMPG ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
3000 - 77 King Street West, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8
Website
https://www.optimindpharma.com
Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities.

Optimind Pharma (XCNQ:OMND) Headlines

No Headlines